Clinical Trials Logo

Female Contraception clinical trials

View clinical trials related to Female Contraception.

Filter by:

NCT ID: NCT00261482 Completed - Contraception Clinical Trials

Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.

Start date: July 2003
Phase: Phase 4
Study type: Interventional

The purpose of the study is to evaluate user experience with the EVRA® Contraceptive Transdermal Patch; specifically, user satisfaction with the EVRA® Patch, and if applicable, user preference of the EVRA® Patch compared with the previous method of contraception. The study also evaluates contraceptive efficacy, safety and user compliance.

NCT ID: NCT00258076 Completed - Contraception Clinical Trials

A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)

Start date: April 2004
Phase: Phase 1
Study type: Interventional

The objective of this study is to estimate the exposure to the hormones norelgestromin, norgestrel, and ethinyl estradiol in the bloodstream of healthy female volunteers across multiple commercial lots of ORTHO EVRA® (a transdermal contraceptive patch) and to compare these data to historical hormonal exposure data from one ORTHO EVRA® clinical development lot.

NCT ID: NCT00258063 Completed - Contraception Clinical Trials

A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)

Start date: May 2004
Phase: Phase 1
Study type: Interventional

The objective of this study is to estimate exposure to the hormones norelgestromin, norgestrel, and ethinyl estradiol in healthy female volunteers across multiple commercial lots of EVRA® (a transdermal contraceptive patch manufactured by LOHMANN Therapie-Systeme), to compare these data to exposure data from one clinical lot, and to compare these data to exposure data from a commercially available oral contraceptive.

NCT ID: NCT00254865 Completed - Contraception Clinical Trials

A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers

Start date: August 2002
Phase: Phase 1
Study type: Interventional

The objective of this study is to compare the levels of the hormones norelgestromin, norgestrel, and ethinyl estradiol in the bloodstream of healthy female volunteers administered ORTHO EVRA® (a transdermal contraceptive patch) and CILEST® (an oral contraceptive). The open-label treatment phase of the study consists of two 28-day cycles of one treatment, a washout period of 28 days, and crossover to two 28-day cycles of the other treatment.

NCT ID: NCT00236795 Completed - Contraception Clinical Trials

A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

Start date: January 1997
Phase: Phase 3
Study type: Interventional

The purpose of the study was to compare the contraceptive efficacy and safety of the transdermal patch to Triphasil.

NCT ID: NCT00236769 Completed - Contraception Clinical Trials

A Study of Efficacy and Safety With the Transdermal Contraceptive System.

Start date: November 1997
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the contraceptive efficacy, safety, cycle control, and compliance with the transdermal contraceptive system.